✦ LIBER ✦

Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel

✍ Scribed by J. Emilio Exaire; James E. Tcheng; Dean J. Kereiakes; Neal S. Kleiman; Robert J. Applegate; David J. Moliterno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular closure devices and the risk of

✍ Frederic S Resnic; Gavin J Blake; Lucila Ohno-Machado; Andrew P Selwyn; Jeffrey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Incidence and Predictors of Major Vascul

✍ RICHARD KONSTANCE; JAMES E. TCHENG; MARILYN B. WIGHTMAN; LARRY P. KELLY; ANNETTE 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Efficacy and safety of clopidogrel pretr

✍ Marc S. Sabatine; Hussam N. Hamdalla; Shamir R. Mehta; Keith A.A. Fox; Eric J. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 400 KB

Risk factors for the development of retr

✍ H.M. Omar Farouque; Jennifer A. Tremmel; Farshad Raissi Shabari; Meenakshi Aggar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Safety and efficacy of glycoprotein IIb/

✍ W. Jaber; C.S. Rihal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Change of glycoprotein IIb/IIIa inhibito

✍ James Reilly; Dinora Matute; Cynthia Cruz; Michael Benz; Preet Randhawa; Ceyone 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB